LUNG
HealthcarePulmonx Corporation
$1.68-0.10 (-5.62%)
Prev Close
$1.78
Open
$1.76
High
$1.85
Low
$1.62
Volume
476.3K
Market Cap
$75.3M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Pulmonx Corporation (LUNG) has been dominated by selling, with 1 insider purchase totaling $71.4K and 18 insider sales totaling $714.6K. The most recent insider transaction was by French Glendon E. III (director, officer: President and CEO), who sold $193.9K worth of shares on Mar 4, 2026. Pulmonx Corporation operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $75.3M.
Buys (12M)
1
$71.4K
Sells (12M)
18
$714.6K
Net Activity
Net Seller
$643.3K
Active Insiders
9
last 12 mo
LUNG Price Chart
LUNG Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | French Glendon E. III | director, officer: President and CEO | Sell | 135,626 | $1.43 | $193.9K | 1,474,620 |
| Mar 4, 2026↗ | Lehman David Aaron | officer: GENERAL COUNSEL | Sell | 24,474 | $1.43 | $35.0K | 251,829 |
| Mar 4, 2026↗ | Radhakrishnan Srikanth | officer: Chief Science &Techn. Officer | Sell | 20,966 | $1.43 | $30.0K | 180,463 |
| Mar 4, 2026↗ | Rose Geoffrey Beran | officer: CHIEF COMMERCIAL OFFICER | Sell | 15,464 | $1.43 | $22.1K | 372,631 |
| Dec 8, 2025↗ | Florin Daniel P | Director | Sell | 23,321 | $1.99 | $46.4K | 0 |
| Dec 1, 2025↗ | French Glendon E. III | President and CEO | Sell | 8,805 | $1.57 | $13.8K | 0 |
| Dec 1, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,278 | $1.57 | $16.1K | 0 |
| Dec 1, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,322 | $1.57 | $9.9K | 0 |
| Sep 2, 2025↗ | Joshi Mehul | Chief Financial Officer & PAO | Sell | 7,936 | $1.60 | $12.7K | 0 |
| Sep 2, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 9,769 | $1.60 | $15.6K | 0 |
| Sep 2, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,543 | $1.60 | $10.5K | 0 |
| Sep 2, 2025↗ | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,648 | $1.60 | $15.4K | 0 |
| Jun 12, 2025↗ | Ferrari Richard | Director | Sell | 8,000 | $3.16 | $25.3K | 0 |
| Jun 5, 2025↗ | Florin Daniel P | Director | Buy | 23,321 | $3.06 | $71.4K | 0 |
| Jun 2, 2025↗ | Joshi Mehul | Chief Financial Officer & PAO | Sell | 8,061 | $3.13 | $25.2K | 0 |
| Jun 2, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,457 | $3.13 | $32.7K | 0 |
| Jun 2, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,947 | $3.13 | $21.7K | 0 |
| Jun 2, 2025↗ | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,923 | $3.13 | $31.1K | 0 |
| Mar 20, 2025↗ | French Glendon E. III | Director | Sell | 20,000 | $7.85 | $157.0K | 0 |
| Mar 3, 2025↗ | Joshi Mehul | Chief Financial Officer & PAO | Sell | 14,384 | $7.12 | $102.4K | 0 |
| Mar 3, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 22,355 | $7.65 | $170.9K | 0 |
| Mar 3, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 5,779 | $7.13 | $41.2K | 0 |
| Mar 3, 2025↗ | Williamson Steven S. | PRESIDENT AND CEO | Sell | 27,689 | $7.14 | $197.7K | 0 |
| Feb 20, 2025↗ | French Glendon E. III | Director | Sell | 55,453 | $8.28 | $459.1K | 0 |
| Jan 21, 2025↗ | French Glendon E. III | Sell | 4,547 | $6.52 | $29.6K | 1,069,650 | |
| Dec 4, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,497 | $6.19 | $34.0K | 202,938 |
| Dec 4, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,376 | $6.18 | $27.1K | 295,041 |
| Nov 26, 2024↗ | French Glendon E. III | Sell | 20,000 | $6.63 | $132.6K | 1,071,970 | |
| Oct 21, 2024↗ | French Glendon E. III | Sell | 20,000 | $6.52 | $130.4K | 1,091,970 | |
| Sep 18, 2024↗ | French Glendon E. III | Sell | 20,000 | $8.09 | $161.8K | 1,111,970 | |
| Sep 5, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,765 | $6.69 | $38.6K | 208,684 |
| Sep 5, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,586 | $6.70 | $30.7K | 299,609 |
| Aug 22, 2024↗ | Williamson Steven S. | PRESIDENT AND CEO | Buy | 14,245 | $6.84 | $97.4K | 219,531 |
| Jun 26, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $6.16 | $7.3K | 300,019 |
| Jun 5, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,475 | $6.97 | $38.2K | 214,179 |
| Jun 5, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,297 | $6.97 | $30.0K | 305,115 |
| May 23, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $8.71 | $10.3K | 305,500 |
| Apr 24, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $7.49 | $8.9K | 306,684 |
| Mar 26, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $9.36 | $11.1K | 307,868 |
| Mar 5, 2024↗ | French Glendon E. III | PRESIDENT AND CEO | Sell | 6,954 | $9.06 | $63.0K | 1,122,520 |
| Mar 5, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 4,351 | $9.06 | $39.4K | 149,380 |
| Mar 5, 2024↗ | McKune John | INTERIM CFO | Sell | 1,078 | $9.06 | $9.8K | 48,333 |
| Mar 5, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 3,097 | $9.06 | $28.1K | 242,621 |
| Feb 26, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $14.20 | $16.8K | 243,049 |
| Feb 16, 2024↗ | French Glendon E. III | PRESIDENT AND CEO | Sell | 20,000 | $14.60 | $292.0K | 1,121,340 |
| Jan 24, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $13.13 | $15.5K | 244,233 |
| Jan 22, 2024↗ | French Glendon E. III | PRESIDENT AND CEO | Sell | 10,000 | $12.77 | $127.7K | 1,141,340 |
| Dec 27, 2023↗ | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 1,184 | $12.75 | $15.1K | 245,417 |
| Dec 22, 2023↗ | French Glendon E. III | President and CEO | Sell | 10,000 | $12.42 | $124.2K | 1,151,340 |
| Dec 5, 2023↗ | French Glendon E. III | President and CEO | Sell | 6,676 | $10.34 | $69.0K | 1,166,980 |
Showing 1–50 of 128
1 / 3
LUNG Insider Buying Activity
The following table shows recent insider purchases of Pulmonx Corporation (LUNG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jun 5, 2025↗ | Florin Daniel P | Director | Buy | 23,321 | $3.06 | $71.4K | 0 |
| Aug 22, 2024↗ | Williamson Steven S. | PRESIDENT AND CEO | Buy | 14,245 | $6.84 | $97.4K | 219,531 |
LUNG Insider Selling Activity
The following table shows recent insider sales of Pulmonx Corporation (LUNG) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026↗ | French Glendon E. III | director, officer: President and CEO | Sell | 135,626 | $1.43 | $193.9K | 1,474,620 |
| Mar 4, 2026↗ | Lehman David Aaron | officer: GENERAL COUNSEL | Sell | 24,474 | $1.43 | $35.0K | 251,829 |
| Mar 4, 2026↗ | Radhakrishnan Srikanth | officer: Chief Science &Techn. Officer | Sell | 20,966 | $1.43 | $30.0K | 180,463 |
| Mar 4, 2026↗ | Rose Geoffrey Beran | officer: CHIEF COMMERCIAL OFFICER | Sell | 15,464 | $1.43 | $22.1K | 372,631 |
| Dec 8, 2025↗ | Florin Daniel P | Director | Sell | 23,321 | $1.99 | $46.4K | 0 |
| Dec 1, 2025↗ | French Glendon E. III | President and CEO | Sell | 8,805 | $1.57 | $13.8K | 0 |
| Dec 1, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,278 | $1.57 | $16.1K | 0 |
| Dec 1, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,322 | $1.57 | $9.9K | 0 |
| Sep 2, 2025↗ | Joshi Mehul | Chief Financial Officer & PAO | Sell | 7,936 | $1.60 | $12.7K | 0 |
| Sep 2, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 9,769 | $1.60 | $15.6K | 0 |
| Sep 2, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,543 | $1.60 | $10.5K | 0 |
| Sep 2, 2025↗ | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,648 | $1.60 | $15.4K | 0 |
| Jun 12, 2025↗ | Ferrari Richard | Director | Sell | 8,000 | $3.16 | $25.3K | 0 |
| Jun 2, 2025↗ | Joshi Mehul | Chief Financial Officer & PAO | Sell | 8,061 | $3.13 | $25.2K | 0 |
| Jun 2, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 10,457 | $3.13 | $32.7K | 0 |
| Jun 2, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 6,947 | $3.13 | $21.7K | 0 |
| Jun 2, 2025↗ | Williamson Steven S. | PRESIDENT AND CEO | Sell | 9,923 | $3.13 | $31.1K | 0 |
| Mar 20, 2025↗ | French Glendon E. III | Director | Sell | 20,000 | $7.85 | $157.0K | 0 |
| Mar 3, 2025↗ | Joshi Mehul | Chief Financial Officer & PAO | Sell | 14,384 | $7.12 | $102.4K | 0 |
| Mar 3, 2025↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 22,355 | $7.65 | $170.9K | 0 |
| Mar 3, 2025↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 5,779 | $7.13 | $41.2K | 0 |
| Mar 3, 2025↗ | Williamson Steven S. | PRESIDENT AND CEO | Sell | 27,689 | $7.14 | $197.7K | 0 |
| Feb 20, 2025↗ | French Glendon E. III | Director | Sell | 55,453 | $8.28 | $459.1K | 0 |
| Jan 21, 2025↗ | French Glendon E. III | Sell | 4,547 | $6.52 | $29.6K | 1,069,650 | |
| Dec 4, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,497 | $6.19 | $34.0K | 202,938 |
| Dec 4, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,376 | $6.18 | $27.1K | 295,041 |
| Nov 26, 2024↗ | French Glendon E. III | Sell | 20,000 | $6.63 | $132.6K | 1,071,970 | |
| Oct 21, 2024↗ | French Glendon E. III | Sell | 20,000 | $6.52 | $130.4K | 1,091,970 | |
| Sep 18, 2024↗ | French Glendon E. III | Sell | 20,000 | $8.09 | $161.8K | 1,111,970 | |
| Sep 5, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,765 | $6.69 | $38.6K | 208,684 |
| Sep 5, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,586 | $6.70 | $30.7K | 299,609 |
| Jun 26, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $6.16 | $7.3K | 300,019 |
| Jun 5, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 5,475 | $6.97 | $38.2K | 214,179 |
| Jun 5, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 4,297 | $6.97 | $30.0K | 305,115 |
| May 23, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $8.71 | $10.3K | 305,500 |
| Apr 24, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $7.49 | $8.9K | 306,684 |
| Mar 26, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $9.36 | $11.1K | 307,868 |
| Mar 5, 2024↗ | French Glendon E. III | PRESIDENT AND CEO | Sell | 6,954 | $9.06 | $63.0K | 1,122,520 |
| Mar 5, 2024↗ | Lehman David Aaron | GENERAL COUNSEL | Sell | 4,351 | $9.06 | $39.4K | 149,380 |
| Mar 5, 2024↗ | McKune John | INTERIM CFO | Sell | 1,078 | $9.06 | $9.8K | 48,333 |
| Mar 5, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 3,097 | $9.06 | $28.1K | 242,621 |
| Feb 26, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $14.20 | $16.8K | 243,049 |
| Feb 16, 2024↗ | French Glendon E. III | PRESIDENT AND CEO | Sell | 20,000 | $14.60 | $292.0K | 1,121,340 |
| Jan 24, 2024↗ | Rose Geoffrey Beran | CHIEF COMMERCIAL OFFICER | Sell | 1,184 | $13.13 | $15.5K | 244,233 |
| Jan 22, 2024↗ | French Glendon E. III | PRESIDENT AND CEO | Sell | 10,000 | $12.77 | $127.7K | 1,141,340 |
| Dec 27, 2023↗ | Rose Geoffrey Beran | Chief Commercial Officer | Sell | 1,184 | $12.75 | $15.1K | 245,417 |
| Dec 22, 2023↗ | French Glendon E. III | President and CEO | Sell | 10,000 | $12.42 | $124.2K | 1,151,340 |
| Dec 5, 2023↗ | French Glendon E. III | President and CEO | Sell | 6,676 | $10.34 | $69.0K | 1,166,980 |
LUNG Insiders
Similar Stocks to LUNG
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B